Elon Musk Says He 'Regrets' War Of Words With Trump: 'Went Too Far' - Tesla ( NASDAQ:TSLA )
On Wednesday, Tesla Inc. TSLA and SpaceX CEO Elon Musk said he regretted some of his posts about Donald Trump. What Happened: Musk took to his social media platform, X, formerly Twitter, and said, "I regret some of my posts about President Donald Trump last week. They went too far."
Exclusive | China working to add C919 certification to agenda for July EU summit
China will push for civil aviation to be a topic of discussion at a summit with European Union leaders in July, with particular focus on the certification of the domestically produced C919 aircraft, according to a source with knowledge of the matter.
Oracle Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Oracle ( NYSE:ORCL )
Oracle Corporation ORCL will release earnings results for the fourth quarter, after the closing bell on Wednesday, June 11. Analysts expect the Austin, Texas-based company to report quarterly earnings at $1.64 per share, up from $1.63 per share in the year-ago period.
Ross Gerber Calls Out Warner Bros. Discovery CEO David Zaslav, Saying He's Created 'Zero Value' After The Conglomerate Announced Plans To Split Into Two Companies By 2026 - Warner Bros. Discovery ( NASDAQ:WBD )
On Tuesday, investor Ross Gerber criticized Warner Bros. Discovery WBD CEO David Zaslav for his leadership, calling the company's planned split into two independent public companies a result of a series of poor decisions.
MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies
MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten ...
IREN prices upsized $500 million convertible notes offering
SYDNEY, June 11, 2025 ( GLOBE NEWSWIRE ) -- IREN Limited ( NASDAQ: IREN ) ( ACN 629 842 799 ) ( "IREN" ) today announced the pricing of its offering of $500 million aggregate principal amount of 3.50% convertible senior notes due 2029 ( the "notes" ) in a private offering to persons reasonably ...
LEADING EDGE MATERIALS ANNOUNCES UP TO $4,000,000 NON-BROKERED PRIVATE PLACEMENT
LEADING EDGE MATERIALS ANNOUNCES UP TO C$4,000,000 NON-BROKERED PRIVATE PLACEMENT ...
Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders
Proceeds to advance potentially disruptive, fast-acting therapeutics for treatment-resistant depression and other neuropsychiatric disorders First-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existing drugs such as ketamine
